Artificial Intelligence In Drug Discovery Market Size, Share & Trends Report

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68039-029-7
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2021
  • Industry: Healthcare

Market Segmentation

  • Artificial Intelligence in Drug Discovery Application Outlook (Revenue, USD Million, 2016 - 2030)
    • Drug optimization and repurposing
    • Preclinical testing
    • Others
  • Artificial Intelligence in Drug Discovery Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2030)
    • Oncology
    • Neurodegenerative Diseases
    • Cardiovascular Disease
    • Metabolic Diseases
    • Infectious Disease
    • Others
  • Artificial Intelligence in Drug Discovery Component Outlook (Revenue, USD Million, 2016 - 2030)
    • Software
    • Hardware
    • Others
  • Artificial Intelligence in Drug Discovery Regional Outlook (Revenue, USD Million, 2016 - 2030)
    • North America
      • North America Artificial Intelligence in Drug Discovery Market, By Application
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • North America Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • North America Artificial Intelligence in Drug Discovery Market, By Component
        • Software
        • Hardware
        • Others
      • U.S.
        • U.S. Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • U.S. Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • U.S. Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Canada
        • Canada Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Canada Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Canada Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
    • Europe
      • Europe Artificial Intelligence in Drug Discovery Market, By Application
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • Europe Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • Europe Artificial Intelligence in Drug Discovery Market, By Component
        • Software
        • Hardware
        • Others
      • Germany
        • Germany Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Germany Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Germany Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • U.K.
        • U.K. Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • U.K. Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • U.K. Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • France
        • France Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • France Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • France Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Italy
        • Italy Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Italy Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Italy Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Spain
        • Spain Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Spain Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Spain Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Russia
        • Russia Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Russia Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Russia Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
    • Asia Pacific
      • APAC Artificial Intelligence in Drug Discovery Market, By Application
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • APAC Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • North America Artificial Intelligence in Drug Discovery Market, By Component
        • Software
        • Hardware
        • Others
      • Japan
        • Japan Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Japan Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Japan Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • China
        • China Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • China Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • China Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • India
        • India Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • India Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • India Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • South Korea
        • South Korea Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • South Korea Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • South Korea Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Australia
        • Australia Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Australia Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Australia Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Singapore
        • Singapore Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Singapore Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Singapore Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
    • Latin America
      • LATAM Artificial Intelligence in Drug Discovery Market, By Application
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • LATAM Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • LATAM Artificial Intelligence in Drug Discovery Market, By Component
        • Software
        • Hardware
        • Others
      • Brazil
        • Brazil Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Brazil Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Brazil Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Mexico
        • Mexico Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Mexico Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Mexico Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Argentina
        • Argentina Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Argentina Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Argentina Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
    • MEA
      • MEA Artificial Intelligence in Drug Discovery Market, By Application
        • Drug optimization and repurposing
        • Preclinical testing
        • Others
      • MEA Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
        • Oncology
        • Neurodegenerative Diseases
        • Cardiovascular Disease
        • Metabolic Diseases
        • Infectious Disease
        • Others
      • MEA Artificial Intelligence in Drug Discovery Market, By Component
        • Software
        • Hardware
        • Others
      • South Africa
        • South Africa Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • South Africa Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • South Africa Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • Saudi Arabia
        • Saudi Arabia Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • Saudi Arabia Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • Saudi Arabia Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others
      • UAE
        • UAE Artificial Intelligence in Drug Discovery Market, By Application
          • Drug optimization and repurposing
          • Preclinical testing
          • Others
        • UAE Artificial Intelligence in Drug Discovery Market, By Therapeutic Area
          • Oncology
          • Neurodegenerative Diseases
          • Cardiovascular Disease
          • Metabolic Diseases
          • Infectious Disease
          • Others
        • UAE Artificial Intelligence in Drug Discovery Market, By Component
          • Software
          • Hardware
          • Others

Artificial Intelligence In Drug Discovery Market Dynamics

Driver: Rising Need To Curb Drug Development And Discovery Costs

Higher costs of drug discovery and development process are one of the major factors driving the adoption of Artificial Intelligence (AI) in drug development. According to industry journals, the average novel drug discovery and development costs USD 2.6 billion. This is mainly due to the narrow development testing funnel, which eliminates the majority of the candidate therapies in preclinical and phase 1 trials. Thus, the adoption of AI for faster, more efficient, and cost-effective drug discovery is increasing among pharmaceutical industry stakeholders. Furthermore, target identification and validation for drug development is a crucial step for the overall drug discovery process. Increasing the application of AI in target identification is another factor propelling the adoption of AI in the drug discovery process. In addition, many key players in the healthcare industry are trying to adopt AI-based processes to curb drug development costs. For instance, according to an article published by Reuters, in 2017, AstraZeneca and Berg collaborated on the identification of new drug targets with the help of AI-based analysis of tissue samples. Moreover, key players such as Pfizer, Takeda, Roche, and Sanofi are trying to gain a foothold in the emerging AI-based drug discovery market. For instance, according to a report published by Deloitte, as of 2019, Pfizer disclosed around five deals involving AI. Hence, the increasing importance of AI in the overall healthcare sector is likely to increase its adoption in the drug development process, thereby reducing the total cost of drug discovery and development.

Driver: Rising Prevalence Of Chronic Diseases Supporting Development Of Personalized Drugs

The increase in prevalence of chronic diseases is one of the key factors that has raised the need to understand and diagnose diseases in their early stages. With AI-based deep learning technologies, it would become easy to predict diseases based on their historical health data and simplify the drug discovery process related to a particular condition. Thus, many healthcare firms have started collaborating with AI-based companies for the development of a particular drug, effective for a chronic condition, with the use of AI. For instance, in 2019, GlaxoSmithKline partnered with Exscientia, an AI-driven drug development and discovery company, for the development of drug targeted novel treatment for Chronic Obstructive Pulmonary Disease (COPD). Such instances signify growth potential and rising adoption of AI-based drug discovery processes for chronic conditions. In addition, with the increasing prevalence of chronic conditions, the development of personalized medicine has also increased. The combination of artificial and human intelligence data analytics, offering wide opportunities to further customize medical and drug development approaches, is being frequently used. Many players are aiming at developing personalized drugs with the help of AI-based technologies due to the cost-effective nature of AI technology. For instance, Intel Xeon Processors have been deployed in various hospitals in China for the collection of data concerning the detection of abnormal nodules in thyroid ultrasounds. This data can be utilized for the development of precision medicine. In addition, High Content Screening (HCS) for drug discovery can be useful for the development of personalized drugs for a particular healthcare condition, including chronic diseases. Therefore, due to the rising number of people suffering from chronic conditions, the increasing development of personalized medicine, and the growing number of healthcare & technology companies initiating AI-based models for healthcare processes, such as drug development and discovery, the demand for these tools is anticipated.

Restraint: Big Data And Information Explosion In Healthcare And Drug Discovery

Cognitive computing is widely used in many processes in the healthcare industry such as drug development & and discovery, remote patient monitoring, and patient data collection & and analysis. The amount of healthcare information being generated every day is very large, and it is crucial to capture, store, & and analyze the data to improve healthcare delivery. Different disease patterns, population demographics, and region-specific healthcare issues can be analyzed using big data analytics. These applications and the rising need for data management & and consolidation boost the adoption of AI in healthcare processes, including drug discovery. For instance, in 2018, an automated protocol was used for modeling gene expression data on a large scale. This data can reduce the primary genome analysis required for the drug discovery process. Hence, such instances signify potential growth opportunities for AI-based drug discovery concerning big data. Moreover, many key players and start-ups are aiming to increase their market shares by providing various AI-based big data management solutions for drug discovery and other healthcare processes. For instance, Deep Genomics, a start-up founded in 2015, uses big data consolidation along with machine learning and AI to make the drug discovery process easier. In addition, BergHealth is another start-up that provides AI-based analytics solutions to determine the difference between diseased and healthy environments in patient biology. Therefore, an increasing number of companies working in the AI-based drug discovery segment is anticipated to contribute to the substantial growth of the market during the forecast period.

What Does This Report Include?

This section will provide insights into the contents included in this artificial intelligence in drug discovery market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Artificial intelligence in drug discovery market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Artificial intelligence in drug discovery market quantitative analysis

  • Market size, estimates, and forecast from 2016 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon